24.08.2020 15:04:20
|
XBiotech Shares Surge On FDA Emergency Use Authorization Of Convalescent Plasma
(RTTNews) - XBiotech Inc. (XBIT) announced the FDA issued an emergency use authorization for COVID-19 Convalescent Plasma as a COVID-19 treatment, opening the door for the company's antibody screening technology used to identify Convalescent Plasma. Under Collaboration, BioBridge Global will be using XBiotech's COVID-19 antibody test to identify the convalescent blood products.
XBiotech said the Agency's preliminary findings show that the use of convalescent plasma (or blood with natural anti-COVD-19 antibodies from patients that recovered from the infection) is safe and effective in treating COVID-19.
Shares of XBiotech were up 14% in pre-market trade on Monday.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!